Evidence map›Paper›PMID 37175785›Full record

ArticleInternational journal of molecular sciences2023

Investigation into the Potential Role of

Ifeoma Julieth Dikeocha, Abdelkodose Mohammed Al-Kabsi, Ahmad Faheem Ahmeda, Michael Mathai, Mohammed Abdullah Alshawsh

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Potential Pathogens Associated with Colorectal Cancer.Current pharmaceutical biotechnology · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Ifeoma Julieth DikeochaFaculty of Medicine, University of Cyberjaya, Persiaran Bestari, Cyberjaya 63000, Malaysia.ORCID 0000-0003-1700-828X
Abdelkodose Mohammed Al-KabsiFaculty of Medicine, University of Cyberjaya, Persiaran Bestari, Cyberjaya 63000, Malaysia.ORCID 0000-0003-0660-6049
Ahmad Faheem AhmedaDepartment of Basic Medical Sciences, College of Medicine, Ajman University, Ajman P.O. Box 346, United Arab Emirates.ORCID 0000-0001-5962-9573
Michael MathaiCollege of Health and Biomedicine, Victoria University, Melbourne, VIC 3011, Australia.
Mohammed Abdullah AlshawshDepartment of Pharmacology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia.ORCID 0000-0001-8342-5183
University of Cyberjaya · MYAjman University · AEUniversity of Malaya · MYVictoria University · AU

Funding

Cyberjaya University CRG/01/02/2020University of Malaya ST015-2020
6 · The paper itself

Abstract

Colorectal cancer (CRC) accounts for 10% of all cancer diagnoses and cancer-related deaths worldwide. Over the past two decades, several studies have demonstrated the clinical benefits of probiotic supplementation and some studies have shown that certain probiotics can modulate immunity and strengthen gut microbiota diversity. This study aims to assess the impact of the

Indexed as

Colorectal NeoplasmsGastrointestinal MicrobiomePropionibacterium freudenreichiiAnimalsAzoxymethaneRatsRats, Sprague-DawleyRNA, Ribosomal, 16SAzoxymethaneRNA, Ribosomal, 16Sazoxymethanecolorectal cancermicrobiomeprobioticsPropionibacterium freudenreichii

Identifiers

PMID37175785
PMCPMC10179204
OpenAlexW4367624913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.